For instance, studies have shown that patients on semaglutide can lose up to 15-20% of their body weight over 68 weeks
It also plays an important role in sexual behavior
Klinic in Idaho Falls prioritizes medications with FDA-approved weight-loss indications, like Wegovy, Oral Wegovy, Zepbound, and Foundayo, ensuring compliance and maximizing the chances of insurance coverage
Physical activity interventions If possible, raise the intensity of your workouts by incorporating exercises such as weightlifting, walking, swimming, and other physical activities

Tesofensine May Be Better For: Patients who strongly prefer oral medication over injections Individuals whose eating patterns are driven primarily by cravings, emotional eating, or reward-seeking behavior (dopamine-mediated eating) Patients who have not responded adequately to GLP-1 medications Those who tolerate stimulant-type medications well Individuals without significant cardiovascular risk factors Semaglutide May Be Better For: Patients with type 2 diabetes or prediabetes (dual benefit of weight loss and glycemic control) Individuals with cardiovascular disease or elevated cardiovascular risk (proven cardioprotective benefit) Patients who prefer weekly dosing over daily medication Those who experience primarily volume-driven overeating rather than craving-driven eating Individuals with a history of anxiety or insomnia (since semaglutide does not have stimulant properties) Combination Therapy Some physicians prescribe tesofensine and semaglutide together, leveraging their complementary mechanisms tesofensine addressing central nervous system-mediated cravings while semaglutide handles peripheral satiety and metabolic improvements

These drugs, originally designed for diabetics, have recently become popular for weight loss in some countries as an off-label use